{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T23:40:07Z","timestamp":1748216407634,"version":"3.41.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,25]]},"DOI":"10.7759\/cureus.84798","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T23:08:34Z","timestamp":1748214514000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Anemia With Intraosseous-Intramuscular Hemorrhage in a Patient With Kit-C-Negative Systemic Mastocytosis"],"prefix":"10.7759","author":[{"given":"Natalia","family":"Fongrat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Davichan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0956-z","article-title":"Critical care management of systemic mastocytosis: when every wasp is a killer bee","volume":"19","author":"van der Weide HY","year":"2015","unstructured":"van der Weide HY, van Westerloo DJ, van den Bergh WM. Critical care management of systemic mastocytosis: when every wasp is a killer bee. Crit Care. 2015, 19:238. 10.1186\/s13054-015-0956-z","journal-title":"Crit Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero AC","year":"2006","unstructured":"Garcia-Montero AC, Jara-Acevedo M, Teodosio C, et al.. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood. 2006, 108:2366-72. 10.1182\/blood-2006-04-015545","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani A","year":"2019","unstructured":"Pardanani A. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol. 2019, 94:363-77. 10.1002\/ajh.25371","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24490","article-title":"Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: a nationwide population-based study","volume":"91","author":"Broesby-Olsen S","year":"2016","unstructured":"Broesby-Olsen S, Farkas DK, Vestergaard H, et al.. Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: a nationwide population-based study. Am J Hematol. 2016, 91:1069-75. 10.1002\/ajh.24490","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/jh1279","article-title":"Unraveling the rare entity of KIT D816V-negative systemic mastocytosis","volume":"13","author":"Alyamany R","year":"2024","unstructured":"Alyamany R, Albachir CA, Alsaleh S, et al.. Unraveling the rare entity of KIT D816V-negative systemic mastocytosis. J Hematol. 2024, 13:128-36. 10.14740\/jh1279","journal-title":"J Hematol"},{"key":"ref6","article-title":"Ghost cells: a journey in the dark\u2026","volume":"9","author":"Mehendiratta M","year":"2012","unstructured":"Mehendiratta M, Bishen KA, Boaz K, Mathias Y. Ghost cells: a journey in the dark\u2026. Dent Res J (Isfahan). 2012, 9:S1-8.","journal-title":"Dent Res J (Isfahan)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent P","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017, 129:1420-7. 10.1182\/blood-2016-09-731893","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen T","year":"2011","unstructured":"Kristensen T, Vestergaard H, M\u00f8ller MB. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn. 2011, 13:180-8. 10.1016\/j.jmoldx.2010.10.004","journal-title":"J Mol Diagn"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00321","article-title":"The role of new technologies in myeloproliferative neoplasms","volume":"9","author":"Palumbo GA","year":"2019","unstructured":"Palumbo GA, Stella S, Pennisi MS, et al.. The role of new technologies in myeloproliferative neoplasms. Front Oncol. 2019, 9:321. 10.3389\/fonc.2019.00321","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.629","article-title":"Systemic mastocytosis as an unconventional cause of variceal bleeding: think outside the box","volume":"8","author":"Ahmed M","year":"2016","unstructured":"Ahmed M, Kesavan M, Jilani BN, Ahmed S, Deeb L. Systemic mastocytosis as an unconventional cause of variceal bleeding: think outside the box. Cureus. 2016, 8:e629. 10.7759\/cureus.629","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000247222","article-title":"Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration","volume":"187","author":"Olgun N","year":"1993","unstructured":"Olgun N, Oren H, Oren B, Irken G, Polat M, Cevik N. Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration. Dermatology. 1993, 187:127-9. 10.1159\/000247222","journal-title":"Dermatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2014.955008","article-title":"The serum tryptase test: an emerging robust biomarker in clinical hematology","volume":"7","author":"Valent P","year":"2014","unstructured":"Valent P, Sperr WR, Sotlar K, et al.. The serum tryptase test: an emerging robust biomarker in clinical hematology. Expert Rev Hematol. 2014, 7:683-90. 10.1586\/17474086.2014.955008","journal-title":"Expert Rev Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168960","article-title":"Effects of primary mast cell disease on hemostasis and erythropoiesis","volume":"22","author":"Seidel H","year":"2021","unstructured":"Seidel H, Hertfelder HJ, Oldenburg J, Kruppenbacher JP, Afrin LB, Molderings GJ. Effects of primary mast cell disease on hemostasis and erythropoiesis. Int J Mol Sci. 2021, 22:10.3390\/ijms22168960","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/368819-severe-anemia-with-intraosseous-intramuscular-hemorrhage-in-a-patient-with-kit-c-negative-systemic-mastocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T23:08:35Z","timestamp":1748214515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/368819-severe-anemia-with-intraosseous-intramuscular-hemorrhage-in-a-patient-with-kit-c-negative-systemic-mastocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.84798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,25]]}}}